Section Arrow
ELAN.NYSE
- Elanco Animal Health
Quotes are at least 15-min delayed:2025/07/04 10:40 EDT
Last
 14.64
-0.08 (-0.54%)
Day High 
14.81 
Prev. Close
14.72 
1-M High
14.79 
Volume 
2.01M 
Bid
13.52
Ask
14.68
Day Low
14.57 
Open
14.66 
1-M Low
13.14 
Market Cap 
7.31B 
Currency USD 
P/E 19.63 
%Yield -- 
10-SMA 13.94 
20-SMA 13.91 
50-SMA 12.56 
52-W High 15.78 
52-W Low 8.02 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.75/0.99
Enterprise Value
11.59B
Balance Sheet
Book Value Per Share
12.79
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
4.44B
Operating Revenue Per Share
8.79
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/04 10:40 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.